Results 291 to 297 of about 212,261 (297)

A Comprehensive Analysis of Programmed Cell Death Ligand-1 Expression With the Clone SP142 Antibody in Non–Small-Cell Lung Cancer Patients

Clinical Lung Cancer, 2017
Kazuki Takada, Gouji Toyokawa, Tatsuro Okamoto   +2 more
exaly  

Tumor programmed cell death ligand 1 expression correlates with nodal metastasis in patients with cutaneous squamous cell carcinoma of the head and neck

Journal of the American Academy of Dermatology, 2017
Juana M García-Pedrero, Pablo Martinez-Camblor, Francisco Vázquez-López   +2 more
exaly  

Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1–high T cells

Journal of Allergy and Clinical Immunology, 2016
Young Joon Choi, Mi-Young Song, Jihye Kim   +2 more
exaly  

Prednisone/programmed cell death-1 ligand-1 inhibitors

Reactions Weekly, 2020
openaire   +1 more source

Clinical Significance of Programmed Death-1 Ligand-1 Expression in Patients with Non-Small Cell Lung Cancer: A 5-year-follow-up Study

Tumori, 2012
exaly  

Bevacizumab/programmed cell death-1-ligand-1-inhibitors

Reactions Weekly
openaire   +1 more source

[Programmed death-1/programmed death-ligand 1 pathway and T cell exhaustion in sepsis].

Zhonghua nei ke za zhi
J Y, Zhang, Y, Yang, L, Liu
openaire   +1 more source